United States HR 2115: Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act

Status: Received in the Senate and Read twice and referred to the Committee on Finance. (as of 2019-10-29)

State: United States · Session: 116 · Bill: HR 2115

Subjects: Business records, Government information and archives, Health care costs and insurance, Inflation and prices, Prescription drugs, Retail and wholesale trades

Sponsors: Abigail Davis Spanberger, Brendan F. Boyle, Elissa Slotkin, Jefferson Van Drew, Jodey C. Arrington, Van Taylor

View United States HR 2115 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.